Orion Pharma Statistics

Total Valuation

Orion Pharma has a market cap or net worth of BDT 7.02 billion. The enterprise value is 34.96 billion.

Market Cap	7.02B
Enterprise Value	34.96B

Important Dates

The next estimated earnings date is Wednesday, April 29, 2026.

Earnings Date	Apr 29, 2026
Ex-Dividend Date	n/a

Share Statistics

Orion Pharma has 234.00 million shares outstanding.

Current Share Class	234.00M
Shares Outstanding	234.00M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.25
PB Ratio	0.33
P/TBV Ratio	0.35
P/FCF Ratio	59.73
P/OCF Ratio	9.79
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 66.92, with an EV/FCF ratio of 297.49.

EV / Earnings	-61.40
EV / Sales	11.21
EV / EBITDA	66.92
EV / EBIT	n/a
EV / FCF	297.49

Financial Position

The company has a current ratio of 2.06, with a Debt / Equity ratio of 1.24.

Current Ratio	2.06
Quick Ratio	1.79
Debt / Equity	1.24
Debt / EBITDA	52.00
Debt / FCF	227.59
Interest Coverage	-0.13

Financial Efficiency

Return on equity (ROE) is -2.86% and return on invested capital (ROIC) is -0.12%.

Return on Equity (ROE)	-2.86%
Return on Assets (ROA)	-0.07%
Return on Invested Capital (ROIC)	-0.12%
Return on Capital Employed (ROCE)	-0.12%
Weighted Average Cost of Capital (WACC)	1.13%
Revenue Per Employee	1.06M
Profits Per Employee	-192,745
Employee Count	2,954
Asset Turnover	0.06
Inventory Turnover	1.30

Taxes

In the past 12 months, Orion Pharma has paid 94.78 million in taxes.

Income Tax	94.78M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -7.98% in the last 52 weeks. The beta is -0.73, so Orion Pharma's price volatility has been lower than the market average.

Beta (5Y)	-0.73
52-Week Price Change	-7.98%
50-Day Moving Average	28.42
200-Day Moving Average	30.58
Relative Strength Index (RSI)	53.12
Average Volume (20 Days)	396,080

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Orion Pharma had revenue of BDT 3.12 billion and -569.37 million in losses. Loss per share was -2.43.

Revenue	3.12B
Gross Profit	1.21B
Operating Income	-58.68M
Pretax Income	-534.10M
Net Income	-569.37M
EBITDA	497.28M
EBIT	-58.68M
Loss Per Share	-2.43

Full Income Statement

Balance Sheet

The company has 238.18 million in cash and 26.75 billion in debt, giving a net cash position of -26.50 billion or -113.23 per share.

Cash & Cash Equivalents	238.18M
Total Debt	26.75B
Net Cash	-26.50B
Net Cash Per Share	-113.23
Equity (Book Value)	21.51B
Book Value Per Share	85.74
Working Capital	8.97B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 717.15 million and capital expenditures -599.63 million, giving a free cash flow of 117.52 million.

Operating Cash Flow	717.15M
Capital Expenditures	-599.63M
Free Cash Flow	117.52M
FCF Per Share	0.50

Full Cash Flow Statement

Margins

Gross margin is 38.68%, with operating and profit margins of -1.88% and -18.26%.

Gross Margin	38.68%
Operating Margin	-1.88%
Pretax Margin	-17.13%
Profit Margin	-18.26%
EBITDA Margin	15.95%
EBIT Margin	-1.88%
FCF Margin	3.77%

Dividends & Yields

Orion Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-8.11%
FCF Yield	1.67%

Dividend Details

Stock Splits

The last stock split was on May 27, 2013. It was a forward split with a ratio of 1.2.

Last Split Date	May 27, 2013
Split Type	Forward
Split Ratio	1.2

Scores

Orion Pharma has an Altman Z-Score of 0.53 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.53
Piotroski F-Score	4